Molecular Imaging Agents Market

Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratification, and follow-up of patients with neurological diseases. Imaging agents are the substances designed to improve the imaging output of specific organs, physiological functions, tissues and diseases. Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study.

Molecular Imaging Agents Market contains market size and forecasts of Molecular Imaging Agents in global, including the following market information:

• Global Molecular Imaging Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Molecular Imaging Agents Market Sales, 2017-2022, 2023-2028, (K MT)
• Global top five Molecular Imaging Agents companies in 2021 (%)

The global Molecular Imaging Agents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Small Molecules Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Molecular Imaging Agents include General Electric, Bracco Diagnostic, Eisai and Guerbet, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Molecular Imaging Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Molecular Imaging Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Molecular Imaging Agents Market Segment Percentages, by Type, 2021 (%)

• Small Molecules
• Peptides
• Engineered Protein Fragments
• Aptamers
• Nanoparticles
• Others

Global Molecular Imaging Agents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Molecular Imaging Agents Market Segment Percentages, by Application, 2021 (%)

• Oncology
• Cardiology
• Gastrointestinal Disorders
• Neurology Disorders
• Others

Global Molecular Imaging Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Molecular Imaging Agents Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Molecular Imaging Agents revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Molecular Imaging Agents revenues share in global market, 2021 (%)
• Key companies Molecular Imaging Agents sales in global market, 2017-2022 (Estimated), (K MT)
• Key companies Molecular Imaging Agents sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• General Electric
• Bracco Diagnostic
• Eisai
• Guerbet